Key result
Increased P-wave dispersion predicts ~235% higher odds of new-onset AF in hospitalized COVID-19 patients.
Why the study?
P wave dispersion predicts AF development and relates to inflammation, but its relationship with new-onset AF in hospitalized COVID-19 patients remains to be determined.
Does P-wave dispersion predict the development of new-onset atrial fibrillation in hospitalized COVID-19 patients?
Case-Control (n=123)
Yes
Does P-wave dispersion predict the development of new-onset atrial fibrillation in hospitalized COVID-19 patients?
P-wave dispersion is an independent predictor of new-onset atrial fibrillation in hospitalized COVID-19 patients and correlates with systemic inflammation.
Answers are grounded in this paper and cite their sources.
May aid AF risk stratification in hospitalized COVID-19; hypothesis-generating and requires prospective validation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eren et al. (2023) conducted a case-control in COVID-19 (n=123). P-wave dispersion vs. Lower P-wave dispersion was evaluated on New-onset atrial fibrillation (OR 3.345, 95% CI 1.607-7.697, p=<0.001). Increased P-wave dispersion was an independent predictor of new-onset atrial fibrillation in hospitalized COVID-19 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: